Literature DB >> 33636040

Device-induced platelet dysfunction in patients after left ventricular assist device implantation.

Kristin Klaeske1, Maja-Theresa Dieterlen1, Sandra Eifert1, Ute Scholz2, Jens Garbade1, Khalil Jawad1, Franz Sieg1, Michael A Borger1, Anna L Meyer3.   

Abstract

BACKGROUND: Non-surgical bleeding (NSB) is a major complication after left ventricular assist device (LVAD) implantation. It has been reported that non-physiological shear stress caused by LVADs could alter platelet receptor expression, which leads to bleeding disorders caused by coagulation dysfunctions.
OBJECTIVES: Because bleeding diathesis could be multifactorial, we focused on the combined characterization of platelet receptor expression patterns and oxidative stress to compare patients with NSB and patients without coagulation disorder in a monocentric, prospective study.
METHODS: Blood samples were obtained from LVAD patients with NSB (bleeder group, n = 19) and without NSB (non-bleeder group, n = 20). The platelet receptors platelet endothelial cell adhesion molecule-1 (PECAM-1), glycoprotein (GP)Ibα, P-selectin, CD63, and GPIIb/IIIa, as well as the production of intraplatelet reactive oxygen species (ROS) were quantified by flow cytometry. Aggregation capacity was evaluated by aggregometry.
RESULTS: The surface expression level of P-selectin and GPIbα on platelets was decreased in bleeders (P-selectin: 465 ± 72 U; GPIbα: 435 ± 41 U) compared to non-bleeders (P-selectin: 859 ± 115 U, P < .01; GPIbα: 570 ± 49 U, p = .04). Additionally, the mean fluorescence intensity of ADP-stimulated P-selectin and PECAM-1 expressing platelets were reduced in bleeders (P-selectin: 944 ± 84 U; PECAM-1: 6722 ± 419 U) compared to non-bleeders (P-selectin: 1269 ± 130 U, P = .04; PECAM-1: 8542 ± 665 U, P = .03). Bleeders showed a higher amount of ROS formation in platelets (88.0 ± 2.6%) than non-bleeders (81.5 ± 2.1%, P = .05).
CONCLUSIONS: These findings suggested that changes of three platelet receptors (GPIbα, P-selectin, and PECAM-1) and elevated oxidative stress may play a role in patients with bleeding complications following LVAD implantation. These results might help to explain the high incidence of spontaneous hemorrhage during LVAD support through an altered platelet function.
© 2021 The Authors. Journal of Thrombosis and Haemostasis published by Wiley Periodicals LLC on behalf of International Society on Thrombosis and Haemostasis.

Entities:  

Keywords:  bleeding complication; flow cytometry; heart failure; left ventricular assist device; platelet

Mesh:

Substances:

Year:  2021        PMID: 33636040     DOI: 10.1111/jth.15279

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


  3 in total

1.  Hemostasis Disturbances in Continuous-Flow Left Ventricular Assist Device (CF-LVAD) Patients-Rationale and Study Design.

Authors:  Kuczaj Agnieszka; Hudzik Bartosz; Kaczmarski Jacek; Przybyłowski Piotr
Journal:  J Clin Med       Date:  2022-06-27       Impact factor: 4.964

Review 2.  Coagulation and Transfusion Updates From 2021.

Authors:  Michael Fabbro; Prakash A Patel; Reney A Henderson; Daniel Bolliger; Kenichi A Tanaka; Michael A Mazzeffi
Journal:  J Cardiothorac Vasc Anesth       Date:  2022-04-06       Impact factor: 2.894

3.  A Prospective Observational Study on Multiplate®-, ROTEM®- and Thrombin Generation Examinations Before and Early After Implantation of a Left Ventricular Assist Device (LVAD).

Authors:  Philipp Opfermann; Alessia Felli; Christine Schlömmer; Martin Dworschak; Michele Bevilacqua; Mohamed Mouhieddine; Daniel Zimpfer; Andreas Zuckermann; Barbara Steinlechner
Journal:  Front Med (Lausanne)       Date:  2022-02-25
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.